Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01225250 · ClinicalTrials.gov registry record · NA
Safety and Efficacy Study of Polydioxanone (PDS) Plates in Rhinoplasty
A NA study of Rhinoplasty, sponsored by DeNova Research.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT01225250 is a NA study of Rhinoplasty that has completed, run by DeNova Research. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01225250, a NA study of Rhinoplasty, has completed, sponsored by DeNova Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine efficacy, safety, and ease of cartilaginous grafting using polydioxanone (PDS) plates in comparison to non-plated cartilaginous grafts as performed through an endonasal rhinoplasty approach in patients requiring a caudal septal extension (CSE) graft.
Conditions Studied
Interventions
- DEVICE Polydioxanone (PDS) plates
- PROCEDURE Caudal septal extension graft performed through endonasal rhinoplasty
Study Locations (1)
Illinois
- DeNova Research - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2010-11-24 |
| Est. Completion | 2015-01-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01225250
The ClinicalTrials.gov registry entry for NCT01225250 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is DeNova Research, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Rhinoplasty appearing as the primary indexed condition, and to 2 interventions - of which Polydioxanone (PDS) plates is the first listed.
NCT01225250 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT01225250 about?
NCT01225250 is a clinical study titled "Safety and Efficacy Study of Polydioxanone (PDS) Plates in Rhinoplasty". The purpose of this study is to determine efficacy, safety, and ease of cartilaginous grafting using polydioxanone (PDS) plates in comparison to non-plated cartilaginous grafts as performed through an endonasal rhinoplasty approach in patients requiring a caudal septal extension (CSE) graft.
What is the current status of trial NCT01225250?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2010-11-24. Estimated completion is 2015-01-19.
What conditions does trial NCT01225250 study?
This clinical trial studies the following conditions: Rhinoplasty.
What interventions are being tested in trial NCT01225250?
The interventions under investigation include: Polydioxanone (PDS) plates (DEVICE), Caudal septal extension graft performed through endonasal rhinoplasty (PROCEDURE).
Who is sponsoring clinical trial NCT01225250?
This trial is sponsored by DeNova Research, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01225250 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rhinoplasty
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.